Biohaven Pharmaceutical Holding Co Ltd. (BHVN) saw its shares plummet 6.45% during intraday trading on Monday, marking a significant decline for the healthcare stock.

The sharp drop follows the release of conflicting analyst ratings on the company. According to recent research reports, analysts have expressed divergent views on Biohaven Ltd., creating uncertainty among investors about the stock's prospects.

While the specific details of individual analyst recommendations weren't disclosed in the available reports, the mixed sentiment from financial analysts appears to have contributed to the selling pressure on Biohaven shares during the trading session.